Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. (Q53076446)
Jump to navigation
Jump to search
scientific article published on 29 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. |
scientific article published on 29 March 2018 |
Statements
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. (English)
Shiwen Yuan
Allison C Nugent
Marc S Lener
Minkyung Park
Aaron Yazdian
Elizabeth D Ballard
Fritz A Henn
29 March 2018